BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37503349)

  • 1. IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
    Elcheva IA; Gowda CP; Bogush D; Gornostaeva S; Fakhardo A; Sheth N; Kokolus KM; Sharma A; Dovat S; Uzun Y; Schell TD; Spiegelman VS
    Front Immunol; 2023; 14():1224516. PubMed ID: 37503349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erratum: IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment.
    Frontiers Production Office
    Front Immunol; 2023; 14():1297519. PubMed ID: 37828983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of characteristic IGF2BP expression patterns in distinct B-ALL entities.
    Stoskus M; Gineikiene E; Valceckiene V; Valatkaite B; Pileckyte R; Griskevicius L
    Blood Cells Mol Dis; 2011 Apr; 46(4):321-6. PubMed ID: 21414819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Analysis of the Expression Profile and Prognostic Significance of the IGF2BP Family in Lung Adenocarcinoma.
    Zhou Z; Zhu T; Chen S; Qin S; Huang Y; Liu D
    Curr Cancer Drug Targets; 2022; 22(4):340-350. PubMed ID: 35232349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?
    Bell JL; Wächter K; Mühleck B; Pazaitis N; Köhn M; Lederer M; Hüttelmaier S
    Cell Mol Life Sci; 2013 Aug; 70(15):2657-75. PubMed ID: 23069990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pan-cancer landscape of IGF2BPs and their association with prognosis, stemness and tumor immune microenvironment.
    Shao W; Zhao H; Zhang S; Ding Q; Guo Y; Hou K; Kan Y; Deng F; Xu Q
    Front Oncol; 2022; 12():1049183. PubMed ID: 36686749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the oncofetal IGF2 mRNA-binding protein 3 (IGF2BP3) in cancer.
    Lederer M; Bley N; Schleifer C; Hüttelmaier S
    Semin Cancer Biol; 2014 Dec; 29():3-12. PubMed ID: 25068994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicle-dependent effect of RNA-binding protein IGF2BP1 on melanoma metastasis.
    Ghoshal A; Rodrigues LC; Gowda CP; Elcheva IA; Liu Z; Abraham T; Spiegelman VS
    Oncogene; 2019 May; 38(21):4182-4196. PubMed ID: 30936459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Roles of Insulin-Like Growth Factor 2 mRNA-Binding Protein 2 in Cancer and Cancer Stem Cells.
    Cao J; Mu Q; Huang H
    Stem Cells Int; 2018; 2018():4217259. PubMed ID: 29736175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttranscriptional destabilization of the liver-specific long noncoding RNA HULC by the IGF2 mRNA-binding protein 1 (IGF2BP1).
    Hämmerle M; Gutschner T; Uckelmann H; Ozgur S; Fiskin E; Gross M; Skawran B; Geffers R; Longerich T; Breuhahn K; Schirmacher P; Stoecklin G; Diederichs S
    Hepatology; 2013 Nov; 58(5):1703-12. PubMed ID: 23728852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profile, clinical significance, and biological function of insulin-like growth factor 2 messenger RNA-binding proteins in non-small cell lung cancer.
    Shi R; Yu X; Wang Y; Sun J; Sun Q; Xia W; Dong G; Wang A; Gao Z; Jiang F; Xu L
    Tumour Biol; 2017 Apr; 39(4):1010428317695928. PubMed ID: 28381175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. m
    Wang L; Hui H; Agrawal K; Kang Y; Li N; Tang R; Yuan J; Rana TM
    EMBO J; 2020 Oct; 39(20):e104514. PubMed ID: 32964498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in cancer.
    Huang X; Zhang H; Guo X; Zhu Z; Cai H; Kong X
    J Hematol Oncol; 2018 Jun; 11(1):88. PubMed ID: 29954406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1.
    Elcheva IA; Wood T; Chiarolanzio K; Chim B; Wong M; Singh V; Gowda CP; Lu Q; Hafner M; Dovat S; Liu Z; Muljo SA; Spiegelman VS
    Leukemia; 2020 May; 34(5):1354-1363. PubMed ID: 31768017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade.
    Benci JL; Johnson LR; Choa R; Xu Y; Qiu J; Zhou Z; Xu B; Ye D; Nathanson KL; June CH; Wherry EJ; Zhang NR; Ishwaran H; Hellmann MD; Wolchok JD; Kambayashi T; Minn AJ
    Cell; 2019 Aug; 178(4):933-948.e14. PubMed ID: 31398344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization and RNP formation of IGF2BPs (IGF2 mRNA-binding proteins) is modulated by distinct RNA-binding domains.
    Wächter K; Köhn M; Stöhr N; Hüttelmaier S
    Biol Chem; 2013 Aug; 394(8):1077-90. PubMed ID: 23640942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA binding protein IGF2BP2 expression is induced by stress in the heart and mediates dilated cardiomyopathy.
    Krumbein M; Oberman F; Cinnamon Y; Golomb M; May D; Vainer G; Belzer V; Meir K; Fridman I; Haybaeck J; Poelzl G; Kehat I; Beeri R; Kessler SM; Yisraeli JK
    Commun Biol; 2023 Dec; 6(1):1229. PubMed ID: 38052926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma.
    Gutschner T; Hämmerle M; Pazaitis N; Bley N; Fiskin E; Uckelmann H; Heim A; Groβ M; Hofmann N; Geffers R; Skawran B; Longerich T; Breuhahn K; Schirmacher P; Mühleck B; Hüttelmaier S; Diederichs S
    Hepatology; 2014 May; 59(5):1900-11. PubMed ID: 24395596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tagged actin mRNA dysregulation in IGF2BP1[Formula: see text] mice.
    Núñez L; Buxbaum AR; Katz ZB; Lopez-Jones M; Nwokafor C; Czaplinski K; Pan F; Rosenberg J; Monday HR; Singer RH
    Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2208465119. PubMed ID: 36067310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
    Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
    J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.